NCT07624331

Brief Summary

This prospective randomized clinical trial will evaluate the clinical outcomes of the implant crown fabricated with standard scan body (control) and polyetheretherketone (PEEK) anatomic healing abutment (test).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
28mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Oct 2028

First Submitted

Initial submission to the registry

May 22, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

May 23, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

2.1 years

First QC Date

May 22, 2026

Last Update Submit

May 31, 2026

Conditions

Keywords

Peri-Implant Tissuesvolumetric analysissoft tissue

Outcome Measures

Primary Outcomes (1)

  • volumetric soft tissue analysis

    Three-dimensional volumetric analysis changes at healed sites before implant placement and after implant crown loading

    12 months

Secondary Outcomes (1)

  • volumetric analysis changes

    12 months

Other Outcomes (1)

  • Pink Esthetic White Esthetic Score

    12 months

Study Arms (2)

Group A: Control

PLACEBO COMPARATOR

Monolithic zirconia screw retained crown conditioned with titanium standard healing abutment (SHA) and fabricated with standard monoscan body

Device: standard healing abutment

Group B: PEEK AHA

ACTIVE COMPARATOR

Monolithic zirconia screw retained crown conditioned and fabricated with AHA digital workflow

Device: AHA PEEK

Interventions

AHA PEEKDEVICE

polyetheretherketone (PEEK) anatomic healing abutment versus standard anatomic healing abutment

Group B: PEEK AHA

Titanium healing abutment

Group A: Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • legally competent to provide written informed consent form prior to any study related procedures.
  • Subjects of either sex or aged 18 above
  • requires replacement of a single missing posterior tooth with adequate mesiodistal dimension (≥8 mm)
  • intact adjacent teeth on both sides with existing opposing tooth condition
  • good oral hygiene, plaque score \<25% bpe1
  • adequate keratinized mucosa width (kmw) minimum 6 mm at the edentulous site
  • adequate bone volume to accommodate the planned dental implant placement of 5.5 mm diameter and 10 mm in length as verifified by Cone Beam Computed Tomography (CBCT)
  • adequate interoccusal distance (crown height space) of at least 6mm measured from alveolar crest to the occlusal table.

You may not qualify if:

  • Localized or generalized periodontitis
  • Presence of active acute infection
  • History of malignancy, radiotherapy or chemotherapy
  • Bone metabolic diseases (e.g.: osteogenesis imperfecta, Paget's disease) or current use of medications affecting bone metabolism
  • Untreated bruxism or parafunctional habits Docusign Envelope ID: FFD7C6C1-66CB-4359-9662-63230F769528 22
  • Severe occlusal discrepancy
  • Any medical condition contraindicating implant placement or alter daily activities to a level consistent with ASA (American Society of Anesthesiologist) III classification (including cardiovascular, hepatic, renal, gastrointestinal, metabolic, neurologic, pulmonary, endocrine, autoimmune or psychiatric disorders)
  • Subjects in need of bone grafting at the site of intended implantation site.
  • Subjects that are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Teknologi MARA

Sungai Buloh, Selangor, 42300, Malaysia

RECRUITING

Study Officials

  • Professor Dr Mohd Yusmiaidil Putera Mohd Yusoff, phd

    Universiti Teknologi Mara

    STUDY DIRECTOR

Central Study Contacts

Nur Hafizah Kamar Affendi, master

CONTACT

NORWATI Atikah Mustafa, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
yes, co investogator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, open label, randomized, parallel double arm study for subject in need for dental implant in the posterior mandible with BLX Implant. The group allocation will be as follows: Group A: Control (Participant will received implant supported restoration conditioned with standard healing abutment and fabricated with standard scan body) Group B: Test (Participant will received implant supported restoration conditioned with PEEK anatomic healing abutment)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc Prof

Study Record Dates

First Submitted

May 22, 2026

First Posted

June 3, 2026

Study Start

May 23, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

In in the agreement with Institute of Straumann AG

Locations